AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16888046 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 9
Study 12807386 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 300 mg daily
Number of subjects: 30
Study 12807386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11137977 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming in water at 29 degrees C
Number of subjects: 19
Study 11137977 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming in water at 36 degrees C
Number of subjects: 19
Study 11137977 — intervention group
Group type: COMPARATOR
Intervention: Swimming in water at 29 degrees C vs 36 degrees C (non-trained subjects)
Number of subjects: 19
Study 8841799 — intervention group
Group type: EXPERIMENTAL
Intervention: Various gestational ages and umbilical artery Doppler flow velocity waveforms or CTG variability measures
Number of subjects: 49
Study 8841799 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trials of management
Number of subjects: 49
Study 1738415 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium acetate (Ca Ac)
Number of subjects: 8
Study 1738415 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (CaCO3)
Number of subjects: 8
Study 6322906 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 days treatment with sodium stibogluconate
Number of subjects: 126
Study 6322906 — intervention group
Group type: COMPARATOR
Intervention: More than 20 days treatment with sodium stibogluconate if necessary
Number of subjects: 126
Study 6322906 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamidine (for non-responders)
Number of subjects: 126
Study 6322906 — intervention group
Group type: COMPARATOR
Intervention: More than 20 days treatment with sodium stibogluconate
Number of subjects: 126
Study 31480895 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained coaches' practices
Number of subjects: 76
Study 31480895 — intervention group
Group type: COMPARATOR
Intervention: Untrained coaches' practices
Number of subjects: 76
Study 31480895 — intervention group
Group type: EXPERIMENTAL
Intervention: Games with trained coaches
Number of subjects: 76
Study 31480895 — intervention group
Group type: COMPARATOR
Intervention: Free time
Number of subjects: 76
Study 29407500 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0175‐in 6‐strand stainless steel wire
Number of subjects: 120
Study 29407500 — intervention group
Group type: COMPARATOR
Intervention: 0.0195‐in dead‐soft coaxial wire
Number of subjects: 120
Study 29407500 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 29407500 — intervention group
Group type: EXPERIMENTAL
Intervention: Second group (0.0195‐in dead‐soft coaxial wire)
Number of subjects: 120
Study 26984429 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-contrast multi-detector computed tomography (CT)
Number of subjects: 171
Study 26984429 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 171
Study 24642339 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support system providing un‐intrusive feedback for automatically verifiable rules (specific inter‐related subset of rules)
Number of subjects: 0
Study 24642339 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support system providing un‐intrusive feedback for non‐automatically verifiable rules (feedback framed as actions with positive consequences)
Number of subjects: 0
Study 24642339 — intervention group
Group type: COMPARATOR
Intervention: Clinical decision support system providing un‐intrusive feedback for non‐automatically verifiable rules (feedback framed as inaction with negative consequences)
Number of subjects: 0
Study 22079603 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel (LNG)-containing combination oral contraceptives
Number of subjects: 181
Study 19623693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine matrix IVR
Number of subjects: 24
Study 19623693 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine reservoir IVR
Number of subjects: 24
Study 19623693 — intervention group
Group type: COMPARATOR
Intervention: Placebo IVR
Number of subjects: 24
Study 17890954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrahigh-dose streptokinase (UH-SK n = 8)
Number of subjects: 15
Study 17890954 — intervention group
Group type: COMPARATOR
Intervention: Alteplase (tPA n = 7)
Number of subjects: 15
Study 14981602 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH) with an ultrafiltration rate of 1 L/h
Number of subjects: 24
Study 14981602 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH) with an ultrafiltration rate of 2.5 L/h
Number of subjects: 24
Study 14981602 — intervention group
Group type: COMPARATOR
Intervention: Continuous venovenous hemodialysis (CVVHD) with a dialysate flow rate of 1 L/h
Number of subjects: 24
Study 14981602 — intervention group
Group type: COMPARATOR
Intervention: Continuous venovenous hemodialysis (CVVHD) with a dialysate flow rate of 2.5 L/h
Number of subjects: 24
Study 14981602 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing ultrafiltration volume or dialysate flow
Number of subjects: 24
Study 14981602 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5-L/h hemofiltration mode
Number of subjects: 24
Study 11782981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with tissue plasminogen activator
Number of subjects: 19
Study 11782981 — intervention group
Group type: COMPARATOR
Intervention: Historical control group of 21 sub-6-hour ischemic stroke patients
Number of subjects: 19
Study 9653702 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (400 mg/d orally for 12 weeks)
Number of subjects: 81
Study 9653702 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment, next IVF-ET performed within six months after previous failed cycle)
Number of subjects: 81
Study 8138680 — intervention group
Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 1 mg/kg
Number of subjects: 10
Study 8138680 — intervention group
Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 2 mg/kg
Number of subjects: 10
Study 8138680 — intervention group
Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 4 mg/kg
Number of subjects: 10
Study 8138680 — intervention group
Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) all doses
Number of subjects: 10
Study 8138680 — intervention group
Group type: EXPERIMENTAL
Intervention: E5 (edobacomab) 1 mg/kg and 4 mg/kg
Number of subjects: 10
Study 2817961 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory valve with facemask and noseclip
Number of subjects: 6
Study 2817961 — intervention group
Group type: COMPARATOR
Intervention: Mouthpiece without facemask
Number of subjects: 6
Study 30446161 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine
Number of subjects: 0
Study 30446161 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0
Study 27920119 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone coaching by a family physician (twice a month)
Number of subjects: 161
Study 27920119 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 161
Study 25216712 — intervention group
Group type: EXPERIMENTAL
Intervention: Linseed oil (α-linolenic acid; 7 g ALA/day)
Number of subjects: 59
Study 25216712 — intervention group
Group type: EXPERIMENTAL
Intervention: Echium oil (stearidonic acid; 2 g SDA/day)
Number of subjects: 59
Study 25216712 — intervention group
Group type: EXPERIMENTAL
Intervention: Microalgae oil (docosahexaenoic acid; 2 g DHA/day)
Number of subjects: 59
Study 25216712 — intervention group
Group type: COMPARATOR
Intervention: Sunflower oil (linoleic acid; 10 g LA/day)
Number of subjects: 59
Study 23431993 — intervention group
Group type: EXPERIMENTAL
Intervention: 25‐mg meperidine
Number of subjects: 140
Study 22080314 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 × 5 g Cr monohydrate per day)
Number of subjects: 27
Study 22080314 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation (4 × 5 g maltodextrin per day)
Number of subjects: 27
Study 19300274 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 1126
Study 19300274 — intervention group
Group type: COMPARATOR
Intervention: No Sedation
Number of subjects: 1126
Study 17012044 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral oophorectomy before age 45 years
Number of subjects: 4780
Study 17012044 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral oophorectomy
Number of subjects: 4780
Study 17012044 — intervention group
Group type: COMPARATOR
Intervention: Referent women (no oophorectomy)
Number of subjects: 4780
Study 14704798 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent static dorsiflexion at 50% MVC with leg elevated
Number of subjects: 0
Study 14704798 — intervention group
Group type: COMPARATOR
Intervention: Intermittent static dorsiflexion at 50% MVC with leg down
Number of subjects: 0
Study 14704798 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent static dorsiflexion with occluded muscle blood flow
Number of subjects: 0
Study 14704798 — intervention group
Group type: COMPARATOR
Intervention: Intermittent static dorsiflexion without occluded muscle blood flow
Number of subjects: 0
Study 11421189 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy rehabilitation (one hour, twice weekly) with emphasis on balance training
Number of subjects: 92
Study 11421189 — intervention group
Group type: COMPARATOR
Intervention: Standard information about early ankle mobilisation (Control group)
Number of subjects: 92
Study 11421189 — intervention group
Group type: COMPARATOR
Intervention: Both training and control groups
Number of subjects: 92
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line treatment for relapsing patients
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 60 at diagnosis
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of chemotherapy cycles > 6
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Age > 60
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest radiotherapy
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of relapse
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rates
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Return to work
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic sequelae
Number of subjects: 263
Study 9402175 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical, mental, and psychological states
Number of subjects: 263
Study 8273321 — intervention group
Group type: EXPERIMENTAL
Intervention: Solcoseryl
Number of subjects: 32
Study 8273321 — intervention group
Group type: EXPERIMENTAL
Intervention: DuoDerm
Number of subjects: 32
Study 8273321 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (Eusol)
Number of subjects: 32
Study 2485043 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (dose titration of 2, 4, 6, and 8 mg once daily)
Number of subjects: 32
Study 2485043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 30541474 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (60-min sessions, 2x weekly for 10 weeks)
Number of subjects: 46
Study 30541474 — intervention group
Group type: COMPARATOR
Intervention: Health education (90-min sessions, weekly for 10 weeks)
Number of subjects: 46
Study 27383312 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic melon (250 g per day for 15 days)
Number of subjects: 53
Study 27383312 — intervention group
Group type: COMPARATOR
Intervention: Market melon (250 g per day for 15 days)
Number of subjects: 53
Study 24006357 — intervention group
Group type: EXPERIMENTAL
Intervention: IQP-PV-101
Number of subjects: 49
Study 24006357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 22750359 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypermedia instruction
Number of subjects: 84
Study 22750359 — intervention group
Group type: COMPARATOR
Intervention: Traditional instruction
Number of subjects: 84
Study 20051299 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin plus G-CSF
Number of subjects: 100
Study 20051299 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 100
Study 18588694 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of albendazole every 2 months over a year
Number of subjects: 68
Study 18588694 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 68
Study 16230562 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA) pretreatment followed by intense pulsed light (IPL) treatment
Number of subjects: 20
Study 16230562 — intervention group
Group type: COMPARATOR
Intervention: IPL treatment alone
Number of subjects: 20
Study 11851783 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered 'side-effect' checklists
Number of subjects: 40
Study 11851783 — intervention group
Group type: COMPARATOR
Intervention: No intervention (comparator group)
Number of subjects: 40
Study 10094243 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 39
Study 10094243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 7757133 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day for 5 years
Number of subjects: 0
Study 7757133 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 5 years
Number of subjects: 0
Study 2253903 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 ml radiolabelled beef consommé with 60 g margarine
Number of subjects: 7
Study 2253903 — intervention group
Group type: COMPARATOR
Intervention: 300 ml radiolabelled beef consommé without margarine
Number of subjects: 7
Study 6244611 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumajecta
Number of subjects: 0
Study 6244611 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31067706 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 165
Study 31067706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 31067706 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MET and Placebo
Number of subjects: 165
Study 28822412 — intervention group
Group type: EXPERIMENTAL
Intervention: Han-uvulopalatopharyngoplasty with septoplasty (study group)
Number of subjects: 96
Study 28822412 — intervention group
Group type: COMPARATOR
Intervention: Han-uvulopalatopharyngoplasty (control group)
Number of subjects: 96
Study 26900936 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg)
Number of subjects: 16
Study 26900936 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 24090116 — intervention group
Group type: EXPERIMENTAL
Intervention: Staple wound closure
Number of subjects: 340
Study 24090116 — intervention group
Group type: COMPARATOR
Intervention: Suture wound closure
Number of subjects: 340
Study 24090116 — intervention group
Group type: EXPERIMENTAL
Intervention: African-American race
Number of subjects: 340
Study 24090116 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index ≥30
Number of subjects: 340
Study 24090116 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 340
Study 24090116 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite wound morbidity (disruption or infection)
Number of subjects: 340
Study 21933835 — intervention group
Group type: EXPERIMENTAL
Intervention: AeroChamber Plus with Facemask
Number of subjects: 17
Study 21933835 — intervention group
Group type: EXPERIMENTAL
Intervention: Babyhaler
Number of subjects: 17
Study 21933835 — intervention group
Group type: COMPARATOR
Intervention: Babyhaler/AeroChamber Plus
Number of subjects: 17
Study 19888488 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 28
Study 19888488 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 28
Study 18158675 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated course of physical examination and trunk anatomy (5 small group sessions)
Number of subjects: 39
Study 18158675 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated course of physical examination and trunk anatomy
Number of subjects: 39
Study 18158675 — intervention group
Group type: COMPARATOR
Intervention: Routine anatomy lectures and problem based learning discussions
Number of subjects: 39
Study 17143713 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary brachytherapy
Number of subjects: 1310
Study 17143713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1310
Study 12783373 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib 400 mg daily
Number of subjects: 1106
Study 12783373 — intervention group
Group type: COMPARATOR
Intervention: IFN up to 5 MU/m(2)/d with cytarabine (Ara‐C) 20 mg/m(2)/d for 10 days every month
Number of subjects: 1106
Study 12783373 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib after crossover from IFN
Number of subjects: 1106
Study 12783373 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 1106
Study 12783373 — intervention group
Group type: COMPARATOR
Intervention: IFN
Number of subjects: 1106
Study 10382693 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic NCPAP
Number of subjects: 107
Study 10382693 — intervention group
Group type: COMPARATOR
Intervention: Subtherapeutic NCPAP
Number of subjects: 107
Study 8926345 — intervention group
Group type: EXPERIMENTAL
Intervention: TX11323(A) gel
Number of subjects: 48
Study 8926345 — intervention group
Group type: COMPARATOR
Intervention: Reference gel
Number of subjects: 48
Study 2057701 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of human calcitonin
Number of subjects: 49
Study 2057701 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU of salmon calcitonin
Number of subjects: 49
Study 2057701 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study 7051464 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 unit of packed red cells (mean of 2350 x 10(6) leukocytes, 900 x 10(6) mononuclear cells) 3 times at 15-day intervals
Number of subjects: 65
Study 7051464 — intervention group
Group type: COMPARATOR
Intervention: One transfusion of about 30 ml of blood adjusted to contain 100 x 10(6) mononuclear cells
Number of subjects: 65
Study 31872349 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily
Number of subjects: 150
Study 31872349 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily plus rivaroxaban 2.5 mg twice daily
Number of subjects: 150
Study 31872349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 150
Study 30935897 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 123
Study 30935897 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 123
Study 28829155 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract (600 mg daily)
Number of subjects: 50
Study 28829155 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 50
Study 27348483 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus ribavirin for 8 weeks
Number of subjects: 146
Study 27348483 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus GS-9669 250 mg for 8 weeks
Number of subjects: 146
Study 27348483 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus GS-9669 500 mg for 8 weeks
Number of subjects: 146
Study 27348483 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledipasvir/sofosbuvir plus vedroprevir ± ribavirin for 8 weeks
Number of subjects: 146
Study 25102686 — intervention group
Group type: EXPERIMENTAL
Intervention: Busuishengxue granules
Number of subjects: 60
Study 25102686 — intervention group
Group type: COMPARATOR
Intervention: Zaizaoshengxue tablets
Number of subjects: 60
Study 22350730 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing young orphan adolescents with uniforms, school fees, and community visitors
Number of subjects: 105
Study 22350730 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer community visitors
Number of subjects: 105
Study 19413731 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonleukoreduced PLT concentrates stored at 20 to 24°C for up to 7 days
Number of subjects: 40
Study 19413731 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukoreduced PLT pools
Number of subjects: 40
Study 17665247 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional lateral internal sphincterotomy (up to the dentate line)
Number of subjects: 108
Study 17665247 — intervention group
Group type: COMPARATOR
Intervention: Conservative internal anal sphincterotomy (up to the height of the fissure apex)
Number of subjects: 108
Study 15786529 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 10 mg thrice daily
Number of subjects: 38
Study 15786529 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate 1,000 mg thrice daily
Number of subjects: 38
Study 12088306 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3 mg/kg, twice daily
Number of subjects: 63
Study 12088306 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.5 mg/kg, twice daily
Number of subjects: 63
Study 12088306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 9682182 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (300 mg x 2) during sleep deprivation (N1)
Number of subjects: 8
Study 9682182 — intervention group
Group type: COMPARATOR
Intervention: Placebo during sleep deprivation (N1)
Number of subjects: 8
Study 9682182 — intervention group
Group type: COMPARATOR
Intervention: Modafinil (300 mg x 2) and Placebo during recovery and control nights (N2)
Number of subjects: 8
Study 9682182 — intervention group
Group type: COMPARATOR
Intervention: Modafinil (300 mg x 2) and Placebo during sleep deprivation (N1)
Number of subjects: 8
Study 7878164 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (2.5 mg/kg bodyweight)
Number of subjects: 0
Study 7878164 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (1.2 mg nicotine yield from cigarette with 8 cued puffs)
Number of subjects: 0